Utilizing network pharmacology and experimental validation to explore the potential molecular mechanisms of raw Pinellia ternate in treating esophageal cancer

被引:0
|
作者
Liu, Yanxin [1 ]
Bai, Yunfei [1 ]
Zhang, Jinbang [1 ]
Silva-Filho, Reginaldo [2 ]
Zhu, Qingchun [1 ]
Lei, Zhen [3 ]
机构
[1] Henan Univ Tradit Chinese Med, Henan Prov Hosp Tradit Chinese Med, Affiliated Hosp 2, Dept Pharm, 6 Dongfeng Rd, Zhengzhou 450053, Peoples R China
[2] Fac EBRAMEC, Sao Paulo, Brazil
[3] Henan Univ Tradit Chinese Med, Henan Prov Hosp Tradit Chinese Med, Affiliated Hosp 2, Cent Lab, Zhengzhou, Peoples R China
关键词
Raw Pinellia ternata (RP); esophageal cancer (EC); network pharmacology; PI3K-Akt signal pathway; PI3K/AKT SIGNALING PATHWAY; ACTIVATION; APOPTOSIS;
D O I
10.21037/jgo-23-684
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Esophageal cancer (EC) is a highly lethal malignancy with a grim prognosis and high mortality rates, primarily treated through surgery and radiotherapy. Herbal remedies are emerging as complementary approaches in cancer therapy. Here, we explore the potential therapeutic benefits of Chinese medicine raw Pinellia ternata (RP) in EC using web-based pharmacological methods and cellular experiments.Methods: The chemical components of RP were obtained by data mining via searches of the systematic pharmacology database, analysis platform, and literature on traditional Chinese medicine (TCM). The properties of the main components of RP were calculated using Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP). The potential targets of the components were mined and collected through multiple databases, and the relevant potential targets of efficacy were imported into Search Tool for the Retrieval of Interacting Genes/Proteins (STRING) database to obtain protein interactions. Gene Ontology (GO) enrichment analysis and Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathway enrichment analysis of the potential targets were performed through Metascape. A target-pathway network was established using Cytoscape, and topological analysis was performed on the network so as to obtain the relevant targets and pathways of RP in the treatment of EC. The inhibitory effect of RP on human EC cells was verified by cell experiments.Results: Thirteen bioactive components of RP were screened, 87 related targets were obtained by construction, and 68 co-targets were obtained after taking intersection with EC related genes. The results of the protein-protein interaction (PPI) network analysis of the targets showed that the pharmacodynamic targets of hemicellulose might be closely related to the signaling pathways such as PI3K-Akt, FOS/JUN, and HIF-1. Meanwhile, GO and KEGG enrichment analysis showed that PI3K-Akt was also significantly enriched. The in vitro cellular experiments further indicated that raw hemicrania could inhibit EC through the PI3K-Akt signaling pathway. Conclusions: The pharmacodynamic mechanism of RP in the treatment of esophageal carcinoma was preliminarily revealed, which provided ideas and the basis for further experimental study of RP in the treatment of esophageal carcinoma.
引用
收藏
页码:2006 / 2017
页数:14
相关论文
共 50 条
  • [41] Integration of Network Pharmacology and Experimental Validation to Explore the Pharmacological Mechanisms of Zhuanggu Busui Formula Against Osteoporosis
    Zhang, Huihao
    Zhou, Chengcong
    Zhang, Zhiguo
    Yao, Sai
    Bian, Yishan
    Fu, Fangda
    Luo, Huan
    Li, Yan
    Yan, Shuxin
    Ge, Yuying
    Chen, Yuying
    Zhan, Kunyu
    Yue, Ming
    Du, Weibin
    Tian, Kun
    Jin, Hongting
    Li, Xiaofeng
    Tong, Peijian
    Ruan, Hongfeng
    Wu, Chengliang
    FRONTIERS IN ENDOCRINOLOGY, 2022, 12
  • [42] Integrating network pharmacology and experimental verification to explore the pharmacological mechanisms of Guanxin Shutong capsule in treating heart failure
    Yang, Zheming
    Li, Jiayin
    Song, Haixu
    Wu, Hanlin
    Zhang, Shuli
    Mei, Zhu
    Xue, Yu
    Zhang, Xiaolin
    Yan, Chenghui
    Han, Yaling
    MEDICINE, 2024, 103 (42)
  • [43] Based on network pharmacology to explore the molecular mechanisms of astragalus membranaceus for treating T2 diabetes mellitus
    Li, Jie
    Huang, Yanqin
    Zhao, Sen
    Guo, Qiuyue
    Zhou, Jie
    Han, Wenjing
    Xu, Yunsheng
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (22)
  • [44] An evidence update to explore molecular targets and protective mechanisms of apigenin against abdominal aortic aneurysms based on network pharmacology and experimental validation
    Li, Dongyu
    Wang, Lei
    Jiang, Bo
    Miao, Yuxi
    Li, Xuan
    MOLECULAR DIVERSITY, 2023, 28 (5) : 2913 - 2929
  • [45] Exploring the mechanism and experimental validation of Fuzi Lizhong Tang in treating gastric cancer based on network pharmacology and molecular docking
    Zhang, F. -Y.
    Guo, S. -C.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2023, 27 (19) : 9192 - 9204
  • [46] Integrated network pharmacology and experimental verification to explore the potential mechanism of San Ying decoction for treating triple-negative breast cancer
    Yang, Xiaojuan
    Li, Feifei
    Shi, Youyang
    Wu, Yuanyuan
    Yang, Rui
    Liu, Xiaofei
    Zhang, Yang
    Zhang, Guangtao
    Ma, Mei
    Luo, Zhanyang
    Han, Xianghui
    Xie, Ying
    Liu, Sheng
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2024, 56 (05): : 763 - 775
  • [47] Integrating Network Pharmacology and Experimental Verification to Explore the Pharmacological Mechanisms of Aloin Against Gastric Cancer
    Gao, Jia
    Yang, Sifu
    Xie, Guanqun
    Pan, Jieli
    Zhu, Feiye
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2022, 16 : 1947 - 1961
  • [48] Investigating the Molecular Mechanisms of Resveratrol in Treating Cardiometabolic Multimorbidity: A Network Pharmacology and Bioinformatics Approach with Molecular Docking Validation
    Gong, Wei
    Sun, Peng
    Li, Xiujing
    Wang, Xi
    Zhang, Xinyu
    Cui, Huimin
    Yang, Jianjun
    NUTRIENTS, 2024, 16 (15)
  • [49] Mechanism of Lycium barbarum in treating periodontitis based on network pharmacology, molecular docking, and experimental validation
    Ma, Lin-Sha
    Jia, Xue-Ting
    Hu, Fa-Quan
    Zheng, Yu-Jiao
    Huang, Xiao-Feng
    Rausch-Fan, Xiaohui
    Fan, Xiao-Chuan
    CLINICAL ORAL INVESTIGATIONS, 2025, 29 (04)
  • [50] Mechanisms of Actinidia chinensis Planch in treating colon cancer based on the integration of network pharmacology, molecular docking, and experimental verification
    Chen, Jin-Fang
    Wu, Shi-Wei
    Shi, Zi-Man
    Qu, Yan-Jie
    Ding, Min-Rui
    Hu, Bing
    HEREDITAS, 2023, 160 (01)